Asset-swap deal sealed
By Ding Yining |
January 4, 2017, Wednesday
|
Print Edition
Print Edition
GERMANY’S Boehringer Ingelheim said it has officially completed the merger of its animal health care business with France-based Sanofi’s Merial as global pharmaceutical giants focus on core businesses while divesting loss-making units.
The two firms said in June last year they agree to an asset-swap deal where Sanofi would sell Merial, valued at 11.4 billion euros (US$11.9 billion), to Boehringer Ingelheim, whilst it would buy Boehringer’s consumer health care division, valued at 6.7 billion euros, and 4.7 billion euros in cash.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
